Latest New Zealand News

Inghams Group has unveiled a comprehensive strategy to stabilise operations, optimise assets, and grow value, reaffirming FY26 EBITDA guidance between $180 million and $200 million amid ongoing cost pressures.

Navigator Global Investments (ASX: NGI) has kicked off a fully underwritten entitlement offer to raise A$145 million, supporting its US$195 million acquisition of a portfolio of alternative asset manager stakes from Stable Asset Management.

Cash Converters reports solid 1H26 results driven by a growing loan book, expanding luxury retail footprint, and increased corporate store ownership across 15 countries.

Santana Minerals has corrected its timeline for settling the purchase of 3,680 hectares for its Bendigo-Ophir Project, extending the deadline to the earlier of mid-2030 or 12 months after mining consents are granted.

Pacific Edge is raising NZ$24 million to shore up its finances and support a crucial Medicare re-coverage bid following a steep revenue drop after losing Medicare reimbursement for its bladder cancer test. The company eyes a draft Medicare policy by September 2026 as a potential turning point.

National Storage REIT has been acquired by a Brookfield-GIC consortium, with all stapled securities bought at $2.80 each and key board changes implemented. The company is set to delist from the ASX following the transaction.

Tanami Gold NL (ASX:TAM) is raising $70.5 million through a fully underwritten renounceable rights issue priced at $0.06 per share, a 34.78% discount to the last traded price, to finance development of its Central Tanami Project.

Chatham Rock Phosphate has secured a definitive financing agreement with Wetstone Global that doubles an existing loan to USD 300,000 and converts it into a 30% equity stake, granting Wetstone majority board control and potential for up to 70% ownership upon project milestones.

Amplia Therapeutics and ANZGOG have initiated a clinical trial to test narmafotinib combined with chemotherapy in ovarian cancer patients unresponsive to platinum-based treatment, aiming to improve surgical outcomes and explore biomarker insights.

Schoolblazer reports a modest revenue dip to $55.4m in 1H FY26 amid supply chain and geopolitical headwinds but strengthens its balance sheet with a new $110 million credit facility and advances integration efforts targeting profitability in FY27.

Murray Cod Australia (ASX:MCA) has launched the retail tranche of its fully underwritten $18.6 million entitlement offer at a 43% discount, aiming to convert its record 3,700-tonne biomass into cash and expand processing capacity.

Bremworth Limited and Floorscape Limited have pushed back the deadline for their acquisition scheme to 7 August 2026 after the New Zealand Commerce Commission extended its decision date to 29 May. The deal remains contingent on regulatory approval and shareholder consent.